luteoforol | 24897-98-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: luteoforol
• 英文别名: 2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-4,5,7-triol
• CAS: 24897-98-1
• 化学式: C₁₅H₁₄O₆
• 分子量: 290.273
• InChiKey: FSYDWKPCKNCRDI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  21
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  110
• 氢给体数：
  5
• 氢受体数：
  6

安全信息

• 海关编码：
  2932999099

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 氢碘酸 作用下， 生成 luteoforol
  参考文献：
  名称：

  Nierenstein, Journal of the American Chemical Society, 1924, vol. 46, p. 2795

  摘要：

  DOI：

文献信息

• METHOD FOR ENHANCING DELIVERY OF THERAPEUTIC DRUGS TO TREATMENT SITES
  申请人：Chang Gung University

  公开号：US20190133979A1

  公开（公告）日：2019-05-09

  Disclosed herein is a method for enhancing uptake of magnetic nanoparticles (MNPs) having a therapeutic agent associated therein to a target site (e.g., a tumor), thereby resulting in elevated level of therapeutic agents being accumulated in the target site. The method comprises concurrently administering a sufficient amount of a polyphenolic compound and MNPs to the target site. Also disclosed herein is a method for treating a cancer in a subject. The method comprises concurrently administering an effective amount of the polyphenolic compound and MNPs to the subject, so as to ameliorate or alleviate symptoms associated with the cancer.

  本文揭示了一种增强磁性纳米颗粒（MNPs）对目标部位（例如肿瘤）的吸收的方法，从而导致治疗剂量在目标部位积累的水平升高。该方法包括同时向目标部位注射足够量的多酚化合物和MNPs。本文还揭示了一种治疗患者癌症的方法，该方法包括同时向患者注射有效量的多酚化合物和MNPs，以改善或缓解与癌症相关的症状。
• [EN] BIOLOGICAL FERMENTATION USING DIHYDROXYACETONE AS A SOURCE OF CARBON<br/>[FR] FERMENTATION BIOLOGIQUE UTILISANT DE LA DIHYDROXYACÉTONE COMME SOURCE DE CARBONE
  申请人：KEMBIOTIX LLC

  公开号：WO2017139420A1

  公开（公告）日：2017-08-17

  The present invention relates to the use of hydrocarbons derived from natural gas in the fermentative production of biochemicals including biofuels. More specifically, the present invention provides the method for manufacturing dihydroxyacetone ("DHA") from natural gas, biogas, biomass and CO2 released from industrial plants including electricity-generating plants, steel mills and cement factories and the use of DHA as a source of organic carbon in the fermentative production of biochemicals including biofuels. The present invention comprises three stages. In the first stage of the present invention, syngas and formaldehyde are produced from natural gas, biogas, biomass and CO2 released from industrial plants. In the second stage of the present invention, formaldehyde and syngas are condensed to produce DHA. In the third stage of the present invention, biochemicals including biofuels are produced from DHA using fermentation process involving wild type or genetically modified microbial biocatalysts.

  本发明涉及使用从天然气中提取的碳氢化合物在生物化学品，包括生物燃料的发酵生产中的应用。更具体地说，本发明提供了一种从天然气、沼气、生物质和工业厂房中释放的CO2中制造二羟基丙酮（"DHA"）的方法，以及将DHA作为有机碳源在发酵生产中制造生物化学品，包括生物燃料的应用。本发明包括三个阶段。在本发明的第一阶段中，从天然气、沼气、生物质和工业厂房中释放的CO2中产生合成气和甲醛。在本发明的第二阶段中，甲醛和合成气被凝结成DHA。在本发明的第三阶段中，使用野生型或基因改造的微生物生物催化剂进行发酵过程，从DHA中生产生物化学品，包括生物燃料。
• HAIR DEFORMATION TREATMENT AGENT
  申请人：Kao Corporation

  公开号：EP3228303A1

  公开（公告）日：2017-10-11

  An agent for hair deforming treatment comprising the following components (A) to (C): (A) glyoxylic acid or a hydrate or salt thereof, (B) a compound represented by the following formula (1): wherein R1 represents H or a methyl group, X represents H, OH, or a methoxy group, Y represents H, O, OH, or a methoxy group, Z represents H, an alkyl group, etc., Rx represents H, O, a methoxy group, etc., Ry represents H, OH, an aromatic hydrocarbon group, etc., and the dashed line optionally represents a double bond, and (C) water, wherein the molar ratio of the content of the component (B) to the content of the component (A), (B)/(A), is 0.01 or more and 5 or less.

  一种用于头发变形处理的制剂，由以下成分(A)至(C)组成： (A) 乙醛酸或其水合物或盐、 (B) 下式(1)所代表的化合物： 其中 R1 代表 H 或甲基，X 代表 H、OH 或甲氧基，Y 代表 H、O、OH 或甲氧基，Z 代表 H、烷基等，Rx 代表 H、O、甲氧基等，Ry 代表 H、OH、芳香烃基等，虚线可选代表双键，以及 (C) 水、 其中，组分（B）的含量与组分（A）的含量的摩尔比，(B)/(A)，为 0.01 或以上，5 或以下。
• ACTIVE COMPOUND COMBINATIONS
  申请人：Bayer AG

  公开号：EP3701796A1

  公开（公告）日：2020-09-02

  The present invention relates to active compound combinations, in particular within a fungicide composition, which comprise (A) fluoxapiprolin and (B) at least one biological control agent and/or (C) at least one compound selected from insecticides, acaricides and nematicides. Moreover, the invention relates to compositions comprising such compound combination and to the use thereof as biologically active combinations, especially for control of harmful microorganisms, in particular oomycetes, in crop protection.

  本发明涉及活性化合物组合，特别是杀真菌剂组合物中的活性化合物组合，其中包括(A)氟氧吡咯林和(B)至少一种生物防治剂和/或(C)至少一种选自杀虫剂、杀螨剂和杀线虫剂的化合物。此外，本发明还涉及包含此类化合物组合的组合物，以及将其用作生物活性组合物，特别是在作物保护中用于控制有害微生物，尤其是卵菌。
• METHOD OF PRODUCTION OF STEVIOL GLYCOSIDE SWEETENERS WITH IMPROVED FLAVOR PROFILES
  申请人：The Coca-Cola Company

  公开号：EP3766362A1

  公开（公告）日：2021-01-20

  Steviol glycoside compositions comprising certain proportions of rebaudioside D, rebaudioside M, rebaudioside A, rebaudioside N, rebaudioside O, and rebaudioside E are provided. Sweetener compositions comprising the steviol glycoside compositions and additional substances are also provided. Consumables, particularly beverages and beverage products containing said steviol glycoside compositions, and sweetener compositions comprising the same, are also provided. Methods of preparing the sweetener compositions and consumables are also detailed herein.

  提供了由一定比例的甜菊糖甙 D、甜菊糖甙 M、甜菊糖甙 A、甜菊糖甙 N、甜菊糖甙 O 和甜菊糖甙 E 组成的甜菊糖甙组合物。此外，还提供了由甜菊醇糖苷组合物和其他物质组成的甜味剂组合物。还提供了消费品，特别是含有所述甜菊醇糖苷组合物和甜味剂组合物的饮料和饮料产品。本文还详细介绍了甜味剂组合物和消费品的制备方法。